This study reports on the spatiotemporal dynamics of the expression of estrogen receptors (ERs) in the mouse central nervous system (CNS) during the early postnatal and the peripubertal period. At postnatal day 7 (P7), neurons with strong nuclear immunostaining for both ERa and ERb1 were widely distributed throughout the brain. Sucrose density gradient sedimentation followed by western blotting supported the histochemical evidence for high levels of both ERs at P7. Over the following 2 days, there was a rapid downregulation of ERs. At P9, ERa expression was visible only in the hypothalamic area. Decline in ERb1 expression was slower than that of ERa, and ERa-negative, ERb1-positive cells were observed in the dentate gyrus and walls of third ventricle. Between P14 and P35, ERs were undetectable except for the hypothalamic area. As before P7, the ovary does not produce estrogen but does produce 5a-androstane-3b, 17b-diol (3bAdiol), an estrogenic metabolite of dihydrotestosterone, we examined the effects of high levels of 3bAdiol in the postnatal period. We used CYP7B1 knockout mice which cannot hydroxylate and inactivate 3bAdiol. The brains of these mice are abnormally large with reduced apoptosis. In the early postnatal period, there was 1-week delay in the timing of the reduction in ER expression in the brain. These data reveal that the time when ERs might be activated in the brain is limited to the first 8 postnatal days. In addition, the importance of aromatase has to be reconsidered as the alternative estrogen, 3bAdiol, is important in neuronal function in the postnatal brain.
Introduction
Although the role of estrogen in masculinization of the male rodent brain is well established, 1 its role in feminization of the female brain is still debated. It is thought that estrogen feminizes the female brain between birth and the onset of puberty. 2 The timing of this imprinting will be limited by the expression of estrogen receptors (ERs) ERa and ERb in the brain and the availability of ER ligands, estradiol-17b (E2, a metabolite of testosterone), and 5a-androstane-3b, 17b-diol (3bAdiol, a metabolite of dihydrotestosterone). For a better understanding of sex differentiation of the brain, the expression pattern of ERs needs to be determined.
In human beings, just after puberty, the rate of major depressive disorder increases. 3 The fourth decade of life is also a time when the occurrence rate of major depressive disorder is high, but usually prodromal symptoms occur many years before diagnosis. 4 As estrogen has been thought to be involved in pathophysiology of psychiatric disorders, 5 we need to know its role during development. Despite these needs, very few attempts have been made to investigate lifetime dynamics of ERs in the central nervous system (CNS), [6] [7] [8] [9] and we still cannot predict how the aging or diseased brain will respond to estrogen.
Immunohistochemistry (IHC) of ERs has been an essential part of estrogen studies in the CNS. After the discovery of ERb, 10 it became essential to reexamine the protein map of ERs in the CNS using antibodies that can selectively recognize ERa or ERb. 11 There have been several reports of ERa and ERb1 localization in the brain, 12, 13 but a profile of receptor expression with age is lacking. In the previous IHC study from our group, using a highly specific antibody against ERb1 (ERb 503 IgY), we showed a highlevel expression of ERb1 14 and its importance during embryogenesis. 15, 16 Very little is known about the physiological role of ERb ins, a splice variant of ERb, in which a novel exon encoding a peptide 18 amino acids in length is inserted into the ligand-binding domain. 17, 18 The binding affinity of ERb ins for E2 is 10-to 15-fold lower than that of ERb1. The DNA-binding domain is intact and electrophoretic mobility shift assays have shown binding ability of ERb ins to estrogen responsive element (ERE). [19] [20] [21] It has been proposed that this receptor isoform might act as a dominant negative regulator of estrogen signaling. 19, 22 Interestingly, the affinity of ERb ins for the antiestrogen, Tamoxifen, is similar to that of ERb1. 23 The fetal brain is very well protected from circulating E2 (either coming from maternal circulation or from siblings developing in close proximity), 24 because of the presence of the high-affinity estrogenbinding protein a-fetoprotein (AFP), which circulates at high concentrations in the fetal blood. 25 Before the onset of E2 biosynthesis in the brain that occurs at E18.5, [26] [27] [28] mRNA of ERb1 is already expressed in fetal brain as early as at E10.5.
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ERb1 protein is detected at E12.5, reaches a peak at E18.5 14 and its function can be detected from E14.5.
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Although ERb1 is essential for neuronal migration and cortical layering, E2 itself does not appear to be necessary as the brain of aromatase knockout (ArKO) mice, which cannot make E2, has not been reported to show major neuronal abnormalities. 30, 31 One explanation for the activity of ERb1 in the absence of E2 is the presence of an alternative ligand for this receptor. We hypothesized that estrogenic activity in the fetal brain is due to 3bAdiol. 3bAdiol is secreted by the immature ovaries [32] [33] [34] and testes. 35 As 3bAdiol is synthesized in situ in cells expressing 5a-reductase and 17b-hydroxysteroid dehydrogenase type 7, 36-38 its level in the brain is not affected by AFP. In order to understand the role of 3bAdiol in the developing brain, we have examined the brains of CYP7B1 knockout mice (CYP7B1
À/À
). CYP7B1 is the enzyme responsible for hydroxylation and inactivation of the estrogenicity of 3bAdiol. CYP7B1 À/À mice cannot hydroxylate 3bAdiol and there are therefore high levels of this estrogenic steroid in the brain of these mice.
We here report an enlarged brain and decreased number of apoptotic cells in the brain of the CYP7B1 À/À mice during late fetal life. The brain size normalizes after puberty. We have investigated ERa and ERb1 expression profiles in the early postnatal and peripubertal period of wild-type (WT) and CYP7B1 À/À mouse brains. The time when ERs may cause feminization of the brain is limited to the first 8 postnatal days. In the frontal cortex, there is a window in time when most of the brain is insensitive to estrogen. This timing is delayed in CYP7B1 À/À compared with WT mice suggesting that 3bAdiol is involved in this mechanism and that normal metabolism of this estrogenic steroid is essential for control of ER expression. Our IHC data clearly show that ER expression in the brain is under strict control in a spatiotemporal manner during development.
Materials and methods

Animals
All experiments were approved by Stockholm's Sö dra Fö rsö ksdjursetiska Nämnd and conducted in accordance with the guidelines for the Care and Use of Laboratory Animals. Mice were maintained in a light-(lights on from 0600 to 1800 hours) and temperaturecontrolled environment with free access to laboratory chow (containing soy) and water. CYP7B1
À/À mice, on a C57BL/6J background, were provided by Richard Lathe (Pieta Research, UK). The colony was maintained by breeding of heterozygous pairs. Mice were genotyped by PCR with DNA extracted from tail biopsies. The sex of the perinatal animals (older than E18.5) was determined by inspection of the anogenital distance or by PCR (E13.5 and E18.5) of the SRY gene. The day after mating when vaginal plug was confirmed was designated as E0.5 and the day of birth was designated as P0.
Chemicals and antibodies
The 2, 4, 6, 7-tritiated E2 (100.0 Ci mmol
À1
) was purchased from Perkin-Elmer (Waltham, MA, USA). b-Galactosidase was from Sigma-Aldrich (St Louis, MO, USA). Rabbit polyclonal anti-ERa (MC20) was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Chicken polyclonal anti-ERb1 antibody, chicken polyclonal anti-ERb ins antibody, and rabbit polyclonal anti-ERbLBD antibody were produced in our laboratory. 11 Mouse monoclonal anti-NeuN antibody was from Chemicon (Temecula, CA, USA). Biotinylated anti-rabbit, anti-chicken, and anti-mouse antibodies raised in goats were from Zymed (South San Francisco, CA, USA).
Phenotype analysis
The brain areas and the lateral ventricular size of WT and CYP7B1
À/À were measured on Nissl-stained sections and compared at P0 and P14. Postnatal WT and CYP7B1
À/À mice were weighed at P9 and P14. After decapitation, the brain was dissected out and its wet weight was immediately measured. The number of animals in each group was 10-16. The mean values for each genotype of the same age and sex were compared by Student's t-test and given as mean± s.e.m.
Preparation of neural tissue sections
To obtain fetal brains, pregnant mice were deeply anesthetized with CO 2 and perfused with phosphatebuffered saline (PBS) followed by 4% paraformaldehyde. Embryos were taken out and put on ice, and brains were dissected and postfixed in the same fixative overnight at 4 1C. Offspring of mice were decapitated on each postnatal day. Following decapitation, the brain was removed quickly and fixed using ice-cold 4% paraformaldehyde followed by 72 h postfixation in the same fixative at 4 1C. The brains were processed for 4-mm paraffin sections.
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N Sugiyama et al IHC of ERs IHC was performed as described before. 14 In brief, brain sections were deparaffinized in xylene and rehydrated through graded ethanol. Antigens were retrieved by boiling in 10 mM citrate buffer (pH 6.0). Endogenous peroxidase was quenched with 0.3% hydrogen peroxide in 50% methanol and nonspecific binding blocked with 1% bovine serum albumin (BSA). For ERb1 and ERb ins staining, slides were incubated with 0.15 units ml À1 of b-galactosidase for 2 h at room temperature. Thereafter, sections were incubated with either one of the primary antibodies at appropriate dilutions in PBS containing 0.1% NP40, 1% BSA overnight. After thorough washing, sections were incubated for 1 h with biotinylated secondary antibodies at a 1:200 dilution in PBS. The sections were rinsed and incubated with avidin-biotinylated horseradish peroxidase complex (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA, USA) for 1 h. The peroxidase-substrate reaction was visualized by 3,3-diaminobenzidine (Dako, Carpenteria, CA, USA). The sections were slightly counterstained with hematoxylin. In every run of staining, NeuN immunostaining was included as a positive control for the quality checking of IHC, such as fixation status of the sections. In this report on ER IHC, we focused on male mice of both of WT and CYP7B1 À/À mice.
TUNEL labeling
The terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay was performed as previously described. 39 The brain sections were deparaffinized, rehydrated, and immersed in proteinase K solution (20 mg ml À1 in 10 mM Tris-HCl, pH 7.4) for 30 min at 37 1C. After rinsing, sections were incubated with TUNEL reaction mixture for 1 h at 37 1C (In situ cell death kit; Roche Diagnostic, Mannheim, Germany). TUNEL-positive cells in the ventricular/subventricular zone were counted and the mean value for each genotype, of the same age was compared at E13.5 and E15.5 by Student's t-test, and given as mean±s.e.m. Four to six animals for each group were analyzed.
Sucrose density gradient sedimentation
Sedimentation studies were carried out as described previously. 40, 41 Offspring of the pregnant mice were decapitated on P7. The brain was removed and frozen using dry ice powder, and stored at À80 1C until the time of assay. Frozen brains were pulverized and added to a buffer (for MCF-7 cells the suspension was 100 mg ml À1 buffer, and for mouse brain, it was 1 g ml À1 buffer). Cytosol was obtained by centrifugation of the homogenate for 1 h at 4 1C at 100 000 g. Whole brain cytosol was incubated for 2 h at 4 1C with 10 nM tritiated E2 in the presence or absence of excessive cold E2. In some experiments, after this step, cytosol was incubated with 1 ml MC20 antibody for 10 min on ice. Sucrose density gradients (10-30% (w/v) sucrose) were prepared. Samples of 200 ml were layered on gradients and centrifuged at 4 1C for 16 h at 300 000 g. Successive 100-ml fractions were collected from the bottom, and assayed by liquid scintillation counting.
Western blotting
Following sucrose density gradient sedimentation, fractions were collected and analyzed by western blotting for ERb1. Samples were precipitated with trichloroacetic acid, and the precipitate was washed with methanol. Pellets were dissolved in SDS sample buffer, and the proteins were resolved by SDSpolyacrylamide gel electrophoresis with 4-20% gradient gels (Invitrogen, Carlsbad, CA, USA) as described before. 42, 43 After transfer to PVDF membranes (Applied Biosystems, Foster City, CA, USA), blots were probed with anti-ERbLBD antibody, followed by appropriate secondary antibodies conjugated with horseradish peroxidase. Detection was by enhanced chemiluminescence ECL kit (Amersham Pharmacia, Pittsburgh, PA, USA).
Quantitative real-time PCR
Offspring of mice were decapitated on each postnatal day. The brain was removed and immediately frozen using dry ice powder. Only male mouse brains were analyzed. Total RNA extraction from the whole brain samples was performed by RNseay lipid tissue midi kit (Qiagen GmbH, Germany). Genomic DNA contamination was removed by the treatment with DNase I (Qiagen GmbH). First-strand cDNA synthesis from total RNA was performed by SuperScript III Reverse transcriptase (Invitrogen). The real-time PCR was performed using ABI Prism 7000 Sequence Detection System (Applied Biosystems) on individual cDNA samples from each mouse and each sample was run in duplicate. The primers used for each gene were:
0 -AGCTTATGACCCGCACTTAC. Detected data were normalized to 18S rRNA and expressed relative to P4. The number of animals in each postnatal day was three. To make comparisons between groups, statistical analysis was performed via one-way analysis of variance (ANOVA) followed by Tukey-Kramer's honestly significant difference post hoc test.
Results
Quantification of transcript levels of ERs in WT mouse brain during development
Quantitative real-time PCR with RNA extracted from whole mouse brains showed that ERa, ERb1, and ERb ins mRNA were high on P4. Over the next 10 days, ERb transcripts declined steadily to reach a low level of 50% for ERb1 and 25% for ERb ins of their levels at P4. ERb1 mRNA increased again by P35 in the brain, 
IHC of ERs in CNS of WT mouse during early postnatal and peripubertal periods
At the age of P7, very strong and sharp signals of ERa, and strong to moderate, but distinct nuclear staining of ERb1 were widely distributed in the brain (Figure 2A) . These IHC signals of ERs were shown to be specific, as all signals were ablated on preincubation of the primary antibodies with the antigens against which they were raised. Sucrose density gradient sedimentation ( Figure 2B ) followed by western blotting ( Figure 2C ) using whole brain extracts at P7 also revealed abundant presence of both ER proteins. Two days later, at P9, ERa expression was much reduced, with only a few areas such as the hypothalamus and the amygdala remaining positive (Figures 3a-h) . Diminution of ERb1 expression was slower than that of ERa. In several brain regions including the dentate gyrus of the hippocampus, the medial habenular nucleus, the thalamus and the wall of third ventricle, ERb1-positive cells were observed but ERa expression was not detected in these areas at this age (Figures 3i-p) . At P14 and P35, both ERs were difficult to detect with the exception of very limited parts of the hypothalamic area such as the medial preoptic nucleus and the arcuate nucleus.
Temporal changes in expression of ERs were most representative in the frontal cortex. In this brain region, there was a rapid downregulation of ERs between P7 and P9. As judged from the undetectable levels of ERs, the peripubertal period from P14 to P35 appears to be a window in time when the brain is insensitive to estrogen. Four months after birth, there was a gradual increase in the number of ERa and ERb1 positive cells (Figure 4 ). ERb ins protein was undetectable after birth.
ER expression in the CYP7B1
À/À mouse brain Focusing on the frontal cortex, we also examined ERa and ERb1 expressions in the CYP7B1 À/À mouse brain at the ages of P9, P14, and P35 ( Figure 5 ). At P9, there were several ERa-positive cells and abundant ERb1-positive cells. After P14, ERa expression in the CYP7B1 À/À mouse brain decreased, and ERb1 expression was confined to layer II of the cortex. At P 35, cells positive for ERa or ERb1 were difficult to find. However, there were still a few positive cells. This pattern is different from our observations of WT mouse brain where essentially no ERs are detected between P14 and P35. On the basis of immunohistochemical analysis, the decrease in expression of ERs seemed to be delayed in CYP7B1 À/À mice; ER expression in CYP7B1 À/À mouse brains at P9, P14, and P35 was quite similar to that in WT mice at P7, P9, and P14, respectively (Figures 4 and 5) .
Transient enlargement of forebrain in postnatal CYP7B1
À/À mouse Nissl staining of coronal brain sections revealed an increase in the size of the forebrain area and compression of the lateral ventricles in the CYP7B1 À/À mice between P0 and P14 in both sexes Figure 1 Developmental changes of mRNA expression of ERs. Quantitative real-time PCR was performed on total RNA isolated from the whole brain of P4, P7, P9, P14, P21, and P35 male mice to determine the mRNA expression of ERa, ERb1, and ERb ins. Data were normalized to the internal control, 18S rRNA, and expressed relative to P4. Value represents the mean and s.e.m. Asterisk (*) indicates the significant differences from P4 (P < 0.05 by one-way analysis of variance (ANOVA) followed by the TukeyKramer's honestly significant difference (HSD) post-hoc test); n = 3 for each group.
Dynamics of estrogen receptors in the brain N Sugiyama et al ( Figure 6 ). The wet weights of the brains of CYP7B1 À/À mice were higher than those of WT for both sexes at P9 and P14, although there was no difference in body weight between CYP7B1 À/À and WT mice ( Figure 7 ). By 3 months of age, the size and shape of the brains of CYP7B1 À/À mice had normalized, and were indistinguishable from WT mice (Figure 6 ). At E13.5 and E15.5, there were fewer apoptotic cells in the ventricular/subventricular zone of CYP7B1 À/À mice than in WT mice (Figure 8 ).
Discussion
Reliable IHC staining for ERs in the CNS has been very important for understanding the role of estrogen in sex differentiation, in regulating the neuroendocrine hypothalamus and pituitary axis, and in clinical studies on effects of hormone replacement therapy (HRT) for menopausal syndrome, cerebral ischemic attack, and neurodegenerative disorders. Although IHC is regarded as descriptive, it is the only tool that can be used to identify receptor-expressing cells without losing in situ information. This is especially important in the CNS where positioning of neurons is closely connected to function. As receptor functions are mediated by the receptor protein not mRNA, the protein needs to be measured. Localization of mRNA is useful but not sufficient because the level of mRNA does not always reflect that of receptor protein. Our mRNA data determined by real-time PCR show that with ERb1 and ERb ins the mRNA roughly parallels the protein but this is not the case with ERa. Changes in ERa mRNA expression between birth and puberty were small, although there are dynamic changes of ERa IHC in the frontal cortex during the same period.
The role of ERb ins in the brain during the peripubertal period is also of great interest. Handa et al. 22 have hypothesized that ERb ins may act as a dominant negative, low-affinity ER in the brain. Their hypothesis is based on their IHC observation of colocalization of ERb1 and ERb ins in the preoptic area, the bed nucleus of stria terminalis, and the Dynamics of estrogen receptors in the brain N Sugiyama et al amygdala of the adult rat brain. These are brain areas that are highly sensitive to circulating E2. If Handa et al. 22 are correct, our result that ERb ins mRNA decreases just after birth, suggests that this splice variant of ERb may be playing some modulatory role during embryonic life. One such function could be protection of the fetus from circulating high-level E2 by being a dominant repressor of both ERa and ERb1. Figure 4 Strongly and rapidly downregulated expression of estrogen receptor a (ERa) (left panels) and estrogen receptor b1 (ERb1) (right panels) in the developing mouse forebrain. Expression of ERs in the frontal cerebral cortex (area ranging from the cingulate cortex to the secondary motor cortex) was examined throughout development. Significant reduction of ERa was observed between P7 and P9. From P9, ERa-ir cells were undetectable in these regions. Widely distributed ERb1-ir cells at P7 were confined to the layer II by P9. Between P9 and P14, ERb1-ir was lost. After 4 months of age, immunoreactivities of ERa and ERb1 reappear. Size bar = 50 mm. Figure 3 Much reduced expression of estrogen receptor a (ERa) (a-o) and estrogen receptor b1 (ERb1) (b-p) in the mouse brain at P9. Both ERa-ir and ERb1-ir cells were observed in a limited part of cortex (a and b), hypothalamus (c-f), and the amygdala (g and h). In several brain regions, ERb1 selective expression was observed (i-p). The right panels are adjacent sections of the left panels from the same brains. 3V: 3rd ventricle; Arc: arcuate nucleus; DG: the dentate gyrus of the hippocampus; MePD: medial amygdaloid nucleus, posterodorsal part; MHb: medial habenular nucleus; VMN: ventromedial nucleus of the hypothalamus; S2: secondary somatosensory cortex. Size bar = 50 mm.
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This function would complement the function of AFP. ERb1 expression has been reported in several brain regions such as the hippocampus and the raphe nucleus in the midbrain 44 which were previously thought to be estrogen nonresponsive. In the present study, we report on the dynamic spatiotemporal changes of the two ERs in the late period of CNS development. The high level of ER expression found in the fetal brains is maintained until P7. Thereafter, receptor levels diminish rapidly and by P9, ERa expression is confined to the hypothalamic regions. ERb1 declines more slowly between P7 and P14. At P9, ERb1 was still expressed in the cortex, but mainly in the layer II.
We also show that there is a window in time between P14 and P35 when there is neither ERa nor ERb1 in most of the brain. Thus, in the peripubertal period most of the brain appears to be unresponsive to estrogen. During development and peripubertal period of life, it may be that some organs require E2 whereas other organs do not need E2, or need to avoid E2. This may be particularly true in an elaborate composite organ such as the brain, in which different types of neurons exist close to each other, and where E2 may elicit completely opposite effects on different neurons. It is quite natural to assume that estrogen signaling is modified not only by the level of E2 itself but also by the differential expression levels of ERa and ERb so that each cell can translate one serum concentration of E2 in different suitable ways.
It has previously been shown that during postnatal development in male rodent brain, there is a rapid rise in cell death, with a peak on P7 followed by a sharp decline to negligible levels by P15. In females, there is a less sharp increase in cell death but the period of increased apoptosis is longer and lasts until P25. 45 The apoptosis coincides with the loss of expression of interleukin (IL)-9, a protective cytokine in the CNS. IL-9 and IL-9 receptor mRNA levels in the brain peak on early postnatal days followed by a dynamic decline by P10. 46 The similar temporal decline in ERs and IL-9 suggests a common regulation.
In the developing CNS, estrogen has been shown to have at least two important roles; sex differentiation and cortical neuronal migration. Despite major advances in understanding neuronal development and neuroendocrinology, the hormonal regulation of the developing brain is still insufficiently understood. The discovery of ERb and establishment of IHC for ERb1 and ERb ins have brought us new tools to increase our insight into this important aspect of brain biology.
Our observation of rapid changes in ER expression provokes another important reflection: 2 days in the life of a mouse is the equivalent of 1-2 months of a human being. Although at birth, the state of maturation of the brain is much different in mouse and man, it is reasonable to assume that during postnatal development changes in ERs also occur in the human brain. Changes in hormone levels might well influence brain ER expression and if it does, it can be anticipated that there would be changes in ER expression in the brains not only at birth and puberty but also during the menopausal period and in aging. In rodents, the neuroprotective effect of E2 in the brain has been shown to be different depending on the timing of administration of E2 after ovariectomy. 47 In this regard, the data generated in the recent HRT trials 48 have to be reevaluated to include consideration of the age of subjects selected for HRT. The response of a 70-to 80-year-old woman who has not previously had HRT cannot be expected to be similar to that of a woman at menopause. The brain phenotype in CYP7B1 À/À mice strongly suggests that ER signaling is involved in the physiological regulation of developmental apoptosis and determination of fetal brain size. Interestingly, the bigger brain size in CYP7B1 À/À mice is normalized after puberty. It appears that after puberty, compensatory systems correct the disturbances in ER regulation that were caused by an excessive amount of 3bAdiol prepubertally. This is consistent with a previous finding that CYP7B1 is active in the brain only during early development. 49 Our data indicate that excessive amounts of 3bAdiol inhibit the normal control of expression of ERs suggesting that 3bAdiol has an important role in the regulation of ER expression during development. To our knowledge, animal models that show abnormally large, heavy brain are rare. Krieglstein et al. 50 reported that immunoneutralization of endogenous transforming growth factors-b (TGF-b) prevented ontogenetic neuronal death in the chicken embryo. One possible scenario in the developing brain is that constant activation of ERb1 stimulates production of inhibin and this inhibin blocks the TGF-b signaling. Thus, the CYP7B1 À/À mouse resembles the mouse in which TGF-b is neutralized. One other possible reason for enlargement of CYP7B1 À/À brain could be that ERs might be regulators of IL-9 signaling and 1-week delay of downregulation of ERs may cause the same delay of IL-9 downregulation.
The astonishing fact that the ArKO mouse does not show any severe neuronal abnormality reinforces the À/À mice was significantly increased for both sexes at P9 and P14 as compared with wild type (WT). No differences in body weight of the CYP7B1 À/À as compared with WT could be found for either males or females at both ages. *P < 0.05 versus WT of the same sex and same age; n = 10-16 for each groups. suggestion that knockout of aromatase does not mean complete absence of estrogen. We propose that 3bAdiol might be a main estrogen in the brain especially during development. As early as 1974, 3bAdiol was reported to be estrogenic. 33 In our recent studies, we have shown that 3bAdiol is a strong binder of ERb1 41 and that CYP7B1 is the enzyme that regulates ERb1 function by regulating the level of 3bAdiol. 51, 52 The brain phenotype of the CYP7B1 À/À mouse indicates that 3bAdiol is functional in the developing brain. There are at least two functions of 3bAdiol, one with regard to normal neuronal selection by apoptosis and the other one being participation in the control of ER expression.
There is a consensus that most of childhood and adolescent psychiatric disorders such as pervasive development disorder, attention-deficit hyperactivity disorder, and learning disorder result, at least in part, from an impairment of normal neuronal development. 53 However, the reasons for impaired neuronal development are still obscure. The high expression of ERb1 in the medial habenular nucleus is of great interest as this is the region linking the forebrain with midbrain and hindbrain structures and it is thought to be involved in schizophrenia. The medial habenular nucleus is important in learning, memory, and attention. 54 Our studies suggest that ERs should be considered as novel targets in the prevention and treatment of psychiatric disorders. The CYP7B1 À/À mouse with its defective neuronal developmental system is an interesting animal model for studies on the role of estrogen in neuronal development.
